Capricor Therapeutics (CAPR) Non-Current Debt (2013 - 2024)

Capricor Therapeutics' Non-Current Debt history runs 12 years deep, the most recent figure standing at $3.4 million for Q3 2024.

• In Q3 2024, Non-Current Debt changed 0.0% year-over-year to $3.4 million; the TTM figure through Sep 2024 stood at $3.4 million (changed 0.0% YoY), while the FY2023 annual figure was $3.4 million, changed 0.0% from the prior year.
• Non-Current Debt was $3.4 million for Q3 2024 at Capricor Therapeutics, roughly flat from $3.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $3.4 million in Q1 2020 to a low of $178233.0 in Q2 2020.
• Historically, Non-Current Debt has averaged $3.2 million across 5 years, with a median of $3.4 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Non-Current Debt plunged 94.72% in 2020, then surged 1794.3% in 2021.
• A 5-year view of Non-Current Debt shows it stood at $3.4 million in 2020, then changed by 0.0% to $3.4 million in 2021, then changed by 0.0% to $3.4 million in 2022, then changed by 0.0% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024.
• The last three Non-Current Debt figures came in at $3.4 million (Q3 2024), $3.4 million (Q2 2024), and $3.4 million (Q1 2024), per Business Quant data.